bromocriptine has been researched along with Diabetic Angiopathies in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garg, SK; Michels, AW; Shah, VN | 1 |
| Bell, DS | 2 |
3 review(s) available for bromocriptine and Diabetic Angiopathies
| Article | Year |
|---|---|
Use of non-insulin therapies for type 1 diabetes.
Topics: Allylamine; Animals; Blood Glucose; Bromocriptine; Cardiovascular Diseases; Colesevelam Hydrochloride; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Dipeptidyl-Peptidase IV Inhibitors; Gastrins; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Islet Amyloid Polypeptide; Leptin; Metformin; Sodium-Glucose Transporter 1; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Sulfonylurea Compounds; Thiazolidinediones; United States | 2013 |
Why does quick-release bromocriptine decrease cardiac events?
Topics: Bromocriptine; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Humans; Hypoglycemic Agents; Inflammation; Insulin Resistance; Oxidative Stress; Postprandial Period | 2011 |
Focusing on cardiovascular disease in type 2 diabetes mellitus: an introduction to bromocriptine QR.
Topics: Blood Glucose; Bromocriptine; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dopamine Agonists; Humans; Hyperglycemia; Risk Assessment | 2012 |